Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Active, not recruitingOBSERVATIONAL
Enrollment
6,000
Participants
Timeline
Start Date
May 13, 2025
Primary Completion Date
November 1, 2025
Study Completion Date
June 1, 2026
Conditions
Breast Neoplasms
Trial Locations (1)
150000
Ming Niu, Harbin
All Listed Sponsors
lead
The Third Affiliated Hospital of Harbin Medical University
OTHER
NCT06856616 - Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter